Notch1 mutations, which activate c-myc transcription, were identified in > 50% of T-ALL cases [41-43], suggesting that upregulation of Notch1 or c-Myc phosphorylation occurred via the EGFR/KRAS/MEK/ERK pathway [37]. This evidence concerns the gene KRAS and acute lymphoblastic leukemia.